Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy targetLaura Llaó Cid, Martina Seiffert, Susanne Gonder et al.|Nature Communications|2025Cited by 14
High-dimensional single-cell definition of CLL T cells identifies Galectin-9 as novel immunotherapy targetLaura Llaó Cid, Martina Seiffert, JKL Wong et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 6
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLLLavinia Arseni, Martina Seiffert, Gianluca Sigismondo et al.|Nature Communications|2025Cited by 5
Integrative multi-omics identifies regulatory and exhausted T cell types and novel immunotherapy targets in CLL lymph nodesMartina Seiffert, Elı́as Campo, Laura Llaó Cid et al.|Research Square|2024Cited by 0